Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product.

Abstract

Tubulysin A (tubA) is a natural product isolated from a strain of myxobacteria that has been shown to depolymerize microtubules and induce mitotic arrest. The potential of tubA as an anticancer and antiangiogenic agent is explored in the present study. tubA shows potent antiproliferative activity in a panel of human cancer cell lines irrespective of their multidrug resistance properties. It induces apoptosis in cancer cells but not in normal cells and shows significant potential antiangiogenic properties in several in vitro assays. It is efficacious in initial animal studies using a hollow fibre assay with 12 different human tumour cell lines. This study suggests that both in vitro and preclinical profiles of tubA may translate into clinically useful anticancer properties.

8 Figures and Tables

0501001502008200920102011201220132014201520162017
Citations per Year

384 Citations

Semantic Scholar estimates that this publication has 384 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Kaur2006BiologicalEO, title={Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product.}, author={Gurmeet Kaur and Melinda G. Hollingshead and Susan L. Holbeck and Vesna Schauer-Vukasinovi{\'c} and Richard F. Camalier and Alexander S. D{\"{o}mling and Seema Agarwal}, journal={The Biochemical journal}, year={2006}, volume={396 2}, pages={235-42} }